运动员的肺部和心脏感染
Pulmonary and cardiac infections in athletes.
作者信息
Kruse Roger J, Cantor Cathy L
机构信息
Sports Care/Sports Medicine Fellowship, The Toledo Hospital, Promedica Health System, Toledo, OH 43615, USA.
出版信息
Clin Sports Med. 2007 Jul;26(3):361-82. doi: 10.1016/j.csm.2007.04.002.
Abstract
Pulmonary and cardiac infections in the athlete can have a wide range of presentations and complications. These infections may present few problems for the training athlete or become life threatening. The team physician must be able to make an accurate diagnosis, give the appropriate treatment, understand the potential complications, and ensure proper follow-up and return-to-play protocols.
摘要
运动员的肺部和心脏感染可能有多种表现形式及并发症。这些感染对于正在训练的运动员可能几乎不构成问题，也可能危及生命。队医必须能够做出准确诊断，给予恰当治疗，了解潜在并发症，并确保进行适当的随访以及遵循重返赛场的规程。
相似文献
1
Pulmonary and cardiac infections in athletes.运动员的肺部和心脏感染
Clin Sports Med. 2007 Jul;26(3):361-82. doi: 10.1016/j.csm.2007.04.002.
2
Upper respiratory tract infections in athletes.运动员的上呼吸道感染
Clin Sports Med. 2007 Jul;26(3):345-59. doi: 10.1016/j.csm.2007.04.001.
3
Gastrointestinal infections in the athlete.运动员的胃肠道感染
Clin Sports Med. 2007 Jul;26(3):433-48. doi: 10.1016/j.csm.2007.04.007.
4
Infectious disease and the collegiate athlete.传染病与大学生运动员
Clin Sports Med. 2007 Jul;26(3):449-71. doi: 10.1016/j.csm.2007.04.005.
5
Infectious and lymphocytic myocarditis: epidemiology and factors relevant to sports medicine.感染性和淋巴细胞性心肌炎：流行病学及与运动医学相关的因素
Scand J Med Sci Sports. 1995 Oct;5(5):269-78. doi: 10.1111/j.1600-0838.1995.tb00044.x.
6
Pulmonary infections in the athlete.运动员的肺部感染
Curr Sports Med Rep. 2009 Mar-Apr;8(2):71-5. doi: 10.1249/JSR.0b013e31819c7e87.
7
Environmental and infectious conditions in sports.运动中的环境与感染状况
Clin Sports Med. 2003 Jan;22(1):181-96. doi: 10.1016/s0278-5919(02)00038-8.
8
[Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].[格帕沙星（Vaxar）——用于治疗呼吸道感染的创新型抗生素。研讨会：“格帕沙星——一种专为呼吸道感染设计的新型喹诺酮类药物。瑞士洛桑，1997年5月25日”]
Pneumologie. 1997 Sep;51(9 Suppl):1-4.
9
Cutaneous fungal and viral infections in athletes.运动员的皮肤真菌和病毒感染
Clin Sports Med. 2007 Jul;26(3):397-411. doi: 10.1016/j.csm.2007.04.004.
10
Antimicrobial agents for myocarditis: target the pathway, not the pathogen.用于治疗心肌炎的抗菌药物：针对相关途径，而非病原体。
Heart. 2010 Apr;96(7):494-5. doi: 10.1136/hrt.2009.173740. Epub 2009 Jul 16.
引用本文的文献
1
Respiratory tract infections in athletes.运动员的呼吸道感染
Dis Mon. 2010 Jul;56(7):407-13. doi: 10.1016/j.disamonth.2010.05.001.
本文引用的文献
1
Clinical applications of cardiovascular magnetic resonance imaging.心血管磁共振成像的临床应用
CMAJ. 2006 Oct 10;175(8):911-7. doi: 10.1503/cmaj.060566.
2
Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).流感的预防与控制：免疫实践咨询委员会（ACIP）的建议
MMWR Recomm Rep. 2006 Jul 28;55(RR-10):1-42.
3
Myocarditis: current trends in diagnosis and treatment.心肌炎：诊断与治疗的当前趋势
Circulation. 2006 Feb 14;113(6):876-90. doi: 10.1161/CIRCULATIONAHA.105.584532.
4
Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines.慢性支气管炎所致慢性咳嗽：美国胸科医师学会循证临床实践指南
Chest. 2006 Jan;129(1 Suppl):104S-115S. doi: 10.1378/chest.129.1_suppl.104S.
5
Adacel and Boostrix: Tdap vaccines for adolescents and adults.安尔宝和博思rix：用于青少年及成人的破伤风、白喉、百日咳联合疫苗
Med Lett Drugs Ther. 2006 Jan 16;48(1226):5-6.
6
Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.青少年百日咳的预防：破伤风类毒素、白喉类毒素减少量及无细胞百日咳（Tdap）疫苗的使用建议
Pediatrics. 2006 Mar;117(3):965-78. doi: 10.1542/peds.2005-3038. Epub 2005 Dec 28.
7
Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines.用于百日咳治疗和暴露后预防的推荐抗菌药物：2005年美国疾病控制与预防中心指南
MMWR Recomm Rep. 2005 Dec 9;54(RR-14):1-16.
8
Antiviral drugs for prophylaxis and treatment of influenza.用于预防和治疗流感的抗病毒药物。
Med Lett Drugs Ther. 2005 Nov 21;47(1222):93-5.
9
Troponin: the biomarker of choice for the detection of cardiac injury.肌钙蛋白：用于检测心脏损伤的首选生物标志物。
CMAJ. 2005 Nov 8;173(10):1191-202. doi: 10.1503/cmaj/051291.
10
Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial.秋水仙碱作为复发性心包炎的首选治疗方法：CORE（复发性心包炎的秋水仙碱治疗）试验结果
Arch Intern Med. 2005 Sep 26;165(17):1987-91. doi: 10.1001/archinte.165.17.1987.
Zotero 插件